Duff Wilson

Sanofi-Aventis reveals Genzyme bid

French drug giant Sanofi-Aventis publicly disclosed its $18.5 billion bid for Genzyme on Sunday, intensifying pressure on the U.S. biotechnology company to negotiate a sale.